Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 27, 2015
Pharmacy Choice - Pharmacy News - March 27, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
3/27/15 - Boston Scientific Reports First U.S. Commercial Procedures with WATCHMAN Left Atrial Appendage Closure Device [Health & Beauty Close - Up]
Boston Scientific reported that three patients in the United States received the first implants of its WATCHMAN Left Atrial Appendage Closure Device. The WATCHMAN Device received U.S. Food and Drug Administration approval on Friday, March 13. "Boston Scientific is proud to work with physicians in making a meaningful impact on patient lives by brin
3/27/15 - Dr. Robert Leonard Applauds FDA Clearance of Capillus272Proâ?¢ Hair Loss Laser Cap
Earlier this year, the Capillus272Proâ?¢ received FDA clearance for the promotion of hair regrowth in adult men and women with androgenic alopecia having Ludwig Savin classifications I-II or Norwood Hamilton classifications of IIa-V and Fitzpatrick Classification of Skin phototypes I-IV. "I am extremely excited that the U.S. Food and Drug Administ
3/27/15 - United States : FDA approves treatment for inhalation anthrax [TendersInfo (India)]
The U.S. Food and Drug Administration yesterday approved Anthrasil, Anthrax Immune Globulin Intravenous, to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs. Because Anthrasil was not approved, its use prior to today s approval would have required an emergency use authorization from the FDA.
3/26/15 - Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation
--Cardiologists at Beaumont Hospital, Royal Oak have performed the Midwest's first commercial implant of a device recently approved by the Food and Drug Administration for patients with non-valvular atrial fibrillation. By closing the left atrial appendage, the device has been demonstrated to significantly reduce the risk of death and stroke, compa
3/26/15 - EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Watch Out For ZSAN
The company also intends to commence its phase 3 program in hyperhidrosis for DRM04 in the second half of the year, subject to an end-of-phase 2 meeting with the FDA. Emergent BioSolutions Inc.' s Anthrasil has received FDA approval for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. Anthrasil qualifies for se
3/26/15 - Etiometry Gets FDA 510(k) Clearance for Its T3 Monitor [Professional Services Close - Up]
Etiometry has received FDA 510 clearance for its T3 Monitor product. "FDA approval of the T3 Monitor marks a major milestone in Etiometry's development of the next generation clinical decision support system. The T3 Monitor in concert with the Etiometry Risk Analytics Engine and QI Sandbox software comprise an end-to-end, scalable platform that wi

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Lupus: What You Need to Know
This lesson is supported by:
Drug Therapy Management Series Part II: Psychiatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement